News | April 24, 2023
Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
SÜDPACK is setting standards in terms of both performance and sustainability
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Several late-stage pipeline products have the potential to address some of these unmet needs
Subscribe To Our Newsletter & Stay Updated
